Table 2.
Subjects (N) | Agea | B-ALL | T-ALL (CD19+) | B-CLL | Lymphoma | Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|
Ph1+ or BCRABL1+ | Ph1− or BCRABL1− | MCL | DLBCL | Follicular | Nodular HL | |||||
8 | 32 (9–59) | 2 | 2 | 4 | [23] | |||||
10 | 52 (44–66) | 4 | 4 | 2 | [24] | |||||
16 | 50 (23–74) | 4 | 12 | [25] | ||||||
9 | 39 (15–64) | 5 | 4 | [26] | ||||||
20 | 46 (20–68) | 1 | 4 | 5 | 5 | 5 | [27] | |||
26 | 40 (21–61) | 17 | 1 | 4 | 3 | 1 | [28] | |||
30 | 14 (5–60) | 2 | 27 | 1 | [29] | |||||
6 | 27 (8–44) | 1 | 5 | [18] |
Ph1 Philadelphia1-chromosome, BCRABL1 qRT-PCR result, Ref reference.
aYears (y); median; range.